• 免費註冊
  • 加入官方line@
  • 加入FB粉絲團

台股 » 個股 » 生展 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生展

(8279)
  • 股價
    123.0
  • 漲跌
    ▼2.0
  • 漲幅
    -1.60%
  • 成交量
    32張
  • 產業
    上櫃 生技醫療類股

  • 66人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
生展 (8279)籌碼相關－康和-板橋 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效，來找出真正獲利的贏家所在券商分點，進而追蹤此贏家所操作的股票與軌跡。

股票投資新手教室：一秒知道是否上對大戶列車

康和-板橋 券商分點個股進出

康和-板橋 券商分點全部個股操作績效/獲利分析

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/2200.000.2123.55123.00-0.212-1.93%
2025/01/1600.000125.00124.50013-0.07%
2025/01/1500.000125.00124.50013-0.02%
2025/01/0800.000132.00131.50013-0.02%
2025/01/020.2130.5300.00132.000.2151.39%
2024/12/2000.000.1124.50124.00-0.120-0.53%
2024/12/1800.000.2126.50126.00-0.220-0.94%
2024/12/1600.000.1128.50127.00-0.120-0.48%
2024/12/130.1130.2400.00131.000.1200.30%
2024/12/1200.000.1130.00130.00-0.122-0.27%
2024/12/1100.000130.50130.00021-0.01%
2024/12/1000.000131.00131.00022-0.02%
2024/12/0500.000.1131.00130.00-0.122-0.22%
2024/12/0400.000.2130.76131.00-0.222-0.84%
2024/12/0300.000131.00131.00022-0.02%
2024/12/020127.5000.00130.000220.06%
2024/11/2700.000133.00131.00022-0.06%
2024/11/250.2127.9700.00130.000.2210.70%
2024/11/2000.000.1130.00130.00-0.121-0.55%
2024/11/190.7129.5000.00131.000.7223.36%
2024/11/1500.000.2130.50130.00-0.223-0.84%
2024/11/1200.000132.00131.50024-0.15%
2024/11/110.1135.0000.00135.500.1250.20%
2024/11/0800.000.1136.00135.50-0.124-0.41%
2024/11/0700.000136.50136.00024-0.02%
2024/11/0500.000.2138.50138.00-0.224-0.72%
2024/11/040135.0000.00136.000240.02%
2024/11/010.3135.9500.00137.000.3231.21%
2024/10/2900.000.1131.50131.00-0.123-0.42%
2024/10/2800.000133.00132.50023-0.08%
2024/10/2400.000133.82133.00024-0.17%
2024/10/210.1136.0000.00137.000.1240.28%
2024/10/1800.000134.00133.50024-0.06%
2024/10/1500.000132.50132.00024-0.04%
2024/10/1400.000133.00132.50023-0.04%
2024/10/0900.000.1133.85133.00-0.123-0.22%
2024/10/080.3133.5200.00135.000.3231.48%
2024/09/3000.000133.00132.50023-0.05%
2024/09/2700.000.1132.50132.00-0.123-0.33%
2024/09/2600.000.1134.47133.00-0.122-0.63%
2024/09/2400.000.1132.59132.00-0.121-0.52%
2024/09/230.3133.000.1138.95133.500.2190.88%
2024/09/201135.0000.00136.001185.43%
2024/09/100.1139.0000.00140.000.1150.33%
2024/09/090.1138.0000.00139.000.1130.81%
2024/09/020136.0000.00136.000130.01%
2024/08/0800.000.1133.00132.50-0.113-1.02%
2024/08/0700.000135.50135.00013-0.05%
2024/08/0600.000.1131.10131.00-0.113-0.60%
2024/08/0500.000.2142.06137.50-0.212-1.25%
2024/08/0200.000156.97152.00011-0.29%
2024/08/0100.000159.50159.00011-0.01%
2024/07/290.2156.230.1165.10160.500.1111.21%
2024/07/230.1159.5000.00161.000.1110.84%
2024/07/220.1160.0000.00161.000.1110.79%
2024/07/190160.5000.00162.000110.28%
2024/07/180161.0000.00162.000110.35%
2024/07/160160.0000.00161.000100.18%
2024/07/150159.0000.00160.000100.03%
2024/06/2700.000.1160.52158.00-0.110-0.71%
2024/06/260.1158.000161.50160.000.1100.69%
2024/06/250160.000161.58161.0009-0.37%
2024/06/2400.000.6162.00160.00-0.69-6.27%
2024/06/210.1160.5000.00162.500.1100.89%
2024/06/200.4158.0000.00161.000.4103.82%
2024/06/1900.000.2157.50157.00-0.210-2.18%
2024/06/180154.0000.00156.000100.27%
2024/06/1700.000160.00156.00010-0.05%
2024/06/1400.000.1155.50155.00-0.110-0.92%
2024/06/1300.000.4158.52158.00-0.411-3.33%
2024/06/120.3156.0100.00158.000.3102.35%
2024/06/110.4155.000.1156.37156.500.3112.57%
2024/06/0600.000.1158.50158.00-0.111-1.07%
2024/06/050.1159.0000.00160.000.1111.09%
2024/06/040.3155.0000.00157.000.3102.80%
2024/05/2900.000.2152.22151.50-0.211-2.02%
2024/05/280.2154.000158.15155.000.2111.90%
2024/05/270151.0000.00152.000110.12%
2024/05/2000.000.1152.50150.00-0.110-0.48%
2024/05/170.1145.5000.00153.000.1100.49%
2024/05/1600.000.1153.31152.00-0.110-1.07%
2024/05/100.1154.0000.00155.000.1101.05%
2024/03/2900.000158.50157.50011-0.04%
2024/03/280156.5000.00158.500110.04%
2024/03/2500.000165.00161.00010-0.05%
2024/03/2200.000.3163.67162.00-0.310-2.56%
2024/03/210.3158.5000.00161.000.3102.62%
2024/03/1300.000158.91156.00010-0.21%
2024/03/120157.0000.00157.500100.21%
2024/02/2100.000153.00150.0009-0.01%
〈國光生展望〉子公司安特羅腸病毒三期臨床入尾聲 明年展開IPOAnue鉅亨－2023/12/26
...詳全文
〈國光生展望〉流感疫苗申請巴西藥證+破傷風切新市場 外銷業績拚成長Anue鉅亨－2023/12/26
...詳全文
〈聯合再生展望〉洪傳獻：TOPCon技術明年成主流 獲利表現佳Anue鉅亨－2023/10/16
...詳全文
生展 相關文章